The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo.
about
Interventions for preventing neuropathy caused by cisplatin and related compoundsInterventions for preventing neuropathy caused by cisplatin and related compoundsInterventions for preventing neuropathy caused by cisplatin and related compoundsPeripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatinNorth Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled studyClinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule.Platinum-induced neurotoxicity and preventive strategies: past, present, and futureGhrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.The search for treatments to reduce chemotherapy-induced peripheral neuropathy.Delay of the Blink Reflex in Patients Receiving Platinum-Analogue ChemotherapyAnalgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.
P2860
Q24197763-021B28EE-220A-4556-B0C0-AC83FFF331FAQ24236661-520F8797-6C95-4DFD-B334-C278EC826D85Q24246530-FD6A83D0-4CA8-42C4-81FA-7D2C088E80AFQ28379448-FD25FEE2-48A0-486A-BEF2-08E2613FE3B0Q33717608-185A4B77-E905-4C5C-9C6E-B0699BFF7623Q35055517-7CA4DA56-DB64-4F3A-86D1-B82EEAE5EEDDQ35345734-A6F73887-94B3-4A9C-A8FC-E1DDAF720293Q36415811-8CA66EE7-AF78-41C6-AF7B-BBAECAB1D9F0Q37410650-E10EF234-EDF2-4569-872A-52F8C192524EQ38737787-1559C7D7-3C60-4361-AA73-B8742D5B17BAQ41852990-3D365C5E-CFC8-4EA4-8471-0BFC89A9E19E
P2860
The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The course of neuropathy after ...... ined with Org 2766 or placebo.
@ast
The course of neuropathy after ...... ined with Org 2766 or placebo.
@en
type
label
The course of neuropathy after ...... ined with Org 2766 or placebo.
@ast
The course of neuropathy after ...... ined with Org 2766 or placebo.
@en
prefLabel
The course of neuropathy after ...... ined with Org 2766 or placebo.
@ast
The course of neuropathy after ...... ined with Org 2766 or placebo.
@en
P2093
P356
P1433
P1476
The course of neuropathy after ...... ined with Org 2766 or placebo.
@en
P2093
A Hovestadt
H B Verbiest
M E van der Burg
W L van Putten
P2888
P304
P356
10.1007/BF00833914
P577
1992-03-01T00:00:00Z
P6179
1033676507